These revealed that in addition to CD3 + T cells, IgE treatment was associated with significantly increased CD8+ T cells in tumor, stromal, and necrotic areas, while CD4+ T cell infiltration was significantly increased in tumor areas, as compared to PBS controls (Fig. 5C). This evidence concerns the gene CD4 and neoplasm.